From ASCO 2011: Dr. Joseph Connors Discusses Novel Treatments and New Research in Hodgkin Lymphoma. Interviewed by the editors of Oncology | June 9, 2011.
In this video, Dr. Connors, clinical director at the Centre for Lymphoid Cancer, BC Cancer Agency, and Clinical Professor, University of British Columbia, gives an overview of the results presented at ASCO of the phase II trial of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma, and discusses the most intriguing work currently being done with novel agents used to treat relapsed or refractory Hodgkin lymphoma.
